New Delhi: After announcing probably the highest percentage price hike of 10.76% of essential medicines, the government via a Gazette notification has released the complete cost of 872 essential drugs along with the effective prices from April 1, 2022

Medical Diallgues had ealier reported that based on the basis of Wholesale Price Index (WPI) data provided by the Office of the Economic Advisor, Department for Promotion of Industry and Internal Trade, Ministry of Commerce and Industry whereby the annual change in the WPI works out as 10.76607% during the calendar year 2021 over the corresponding period in 2020, the National Pharmaceutical Pricing Authority (NPPA), apex price regulatory body had announced a price hike of 10.76607% for scheduled drugs-which are under price control.

NLEM lists drugs used to treat common conditions such as fever, infection, heart disease, hypertension, skin diseases and anaemia, among others.

NPPA, has now released the revised prices that will be effective from April 1, 2022.

"The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955," the NPPA stated

Read Also - Highest Ever: NPPA allows price hike of essential medicines by more than 10 percent

Tablet400mg(A)+80mg(B)

Tablet800mg(A)+160mg(B)

Injection10mg/ml(10ml&30ml

Lamivudine(A) +Nevirapine(B)+Stavudine

Tablet300mg(A)+300mg(B)

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection

Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2

Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

Role of acyclovir in Management of chickenpox: Analyzing the importance of starting early

Predicting Poor Neurocognitive Outcomes in Acute Carbon Monoxide Poisoning